Connecting everyone and everything.

We believe every decentralized clinical trial starts with connections. That’s why we take a holistic, highly flexible approach to determine how to best connect investigator site staff with potential study participants, clinicians with enrolled patients, and Fortrea team members with sites and study sponsors.

By understanding the specific needs of patients, sites and sponsors, we can strengthen these key relationships, optimize interactions and improve the overall trial experience.

Reaching more patients with decentralized, virtual and hybrid studies.

Decentralized, virtual and hybrid trials can offer several advantages over the traditional clinical trial model, such as minimizing the patient and caregiver burden, bringing trials closer to difficult-to-reach patients and improving patient diversity.

Recognizing that each study is unique, our unparalleled global network of experienced clinical research professionals and mobile clinicians first determine which DCT solutions make sense for your study, such as eConsent, ePRO solutions, telehealth capabilities or device integrations for digital biomarkers. We then leverage our state-of-the-art technology platform with a highly configurable infrastructure to enable patient-centric services, connecting your digital workflows and delivering a transparent experience for patients, sites and investigators throughout your trial.

Delivering high-touch care through high-tech delivery.

Leveraging advanced technologies in a clinical trial requires intuitive patient engagement. Whether using mobile devices, sensors or applications, our technology platform is engineered to provide comprehensive patient training and support with clear animations and straightforward instructions. Patients can easily navigate application screens for reminders, alerts and dosing diaries and can even use photos or videos to document dosing.

To monitor and guide our patient-centric support for your study, we receive feedback from actual and prospective patients via our Patient Intelligence network. These reports provide up-to-date insights so we can continuously optimize participants’ experiences with their technologies.

Providing a seamless experience for patients.

A pillar of our patient-centric model is a global, in-house ability to bring the clinical trial to your patients. Our DCT services can include mobile clinicians for in-home study drug administration, sampling services (blood draws, biologic sampling and urine collection) and clinical assessments (vital signs, ECGs, weight). Patients can decide where it’s best for a study visit to happen—at home, at school or at work—making the experience truly patient-centric.

Our global network of clinicians can provide patient education to ensure study compliance, chaperone patients to investigator site visits and assist with collecting questionnaire data. We are also experienced at providing direct-to patient (DTP) dispensing and transport of IP, as well as supporting Human Factor Studies.

Recognizing the results.

At Fortrea, our DCT solutions are designed to enhance the experience for patients, investigators and sponsors. We can help you:

• Increase patient reach and diversity to improve trial data
• Reduce patient burden, making it easier for patients to find and enroll in your trial
• Reduce administration time for investigator sites, allowing them to focus on critical patient interactions, either in person or via telehealth
• Increase efficiencies with our global network of mobile clinicians and in-home trial services that can be deployed by investigator sites
• Enable a connected data infrastructure through our easily configurable platform